BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23225231)

  • 1. Development and clinical application of an enzyme immunoassay for the determination of midregional proadrenomedullin.
    Suzuki Y; Itoh H; Katagiri F; Sato F; Sato Y; Kawasaki K; Sato Y; Mimata H; Takeyama M
    J Pept Sci; 2013 Jan; 19(1):59-63. PubMed ID: 23225231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and clinical application of a highly sensitive enzyme immunoassay for determination of N-acetyl-seryl-aspartyl-lysyl-proline.
    Suzuki Y; Itoh H; Katagiri F; Sato F; Kawasaki K; Sato Y; Mimata H; Takeyama M
    J Pept Sci; 2012 Apr; 18(4):276-81. PubMed ID: 22396066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
    Morgenthaler NG; Struck J; Alonso C; Bergmann A
    Clin Chem; 2005 Oct; 51(10):1823-9. PubMed ID: 16099941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
    J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of adrenomedullin in eutopic endometrium and plasma from women with endometriosis.
    Matson BC; Quinn KE; Lessey BA; Young SL; Caron KM
    Fertil Steril; 2018 Jun; 109(6):1072-1078. PubMed ID: 29871794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population.
    Brouwers FP; de Boer RA; van der Harst P; Struck J; de Jong PE; de Zeeuw D; Gans RO; Gansevoort RT; Hillege HL; van Gilst WH; Bakker SJ
    Heart; 2012 Sep; 98(18):1348-53. PubMed ID: 22821276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant decrease in plasma midregional proadrenomedullin level in patients with end-stage renal disease after living kidney transplantation.
    Suzuki Y; Itoh H; Katagiri F; Sato F; Kawasaki K; Sato Y; Sato Y; Mimata H; Takeyama M
    Peptides; 2013 May; 43():102-4. PubMed ID: 23500516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome.
    Zhang F; Li X; Ochs T; Chen L; Liao Y; Tang C; Jin H; Du J
    J Am Coll Cardiol; 2012 Jul; 60(4):315-20. PubMed ID: 22813609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma midregional proadrenomedullin in newborn infants: impact of prematurity and perinatal infection.
    Admaty D; Benzing J; Burkhardt T; Lapaire O; Hegi L; Szinnai G; Morgenthaler NG; Bucher HU; Bührer C; Wellmann S
    Pediatr Res; 2012 Jul; 72(1):70-6. PubMed ID: 22447319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes.
    Lim SC; Morgenthaler NG; Subramaniam T; Wu YS; Goh SK; Sum CF
    Diabetes Care; 2007 Jun; 30(6):1513-9. PubMed ID: 17384335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery.
    Vila G; Riedl M; Maier C; Struck J; Morgenthaler NG; Handisurya A; Prager G; Ludvik B; Clodi M; Luger A
    Obesity (Silver Spring); 2009 Jun; 17(6):1184-8. PubMed ID: 19247278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.
    Christ-Crain M; Morgenthaler NG; Struck J; Harbarth S; Bergmann A; Müller B
    Crit Care; 2005; 9(6):R816-24. PubMed ID: 16356231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis.
    Palladini G; Barassi A; Perlini S; Milani P; Foli A; Russo P; Albertini R; Obici L; Lavatelli F; Sarais G; Casarini S; Moratti R; Melzi d'Eril GV; Merlini G
    Amyloid; 2011 Dec; 18(4):216-21. PubMed ID: 22070520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.
    Neumann JT; Tzikas S; Funke-Kaiser A; Wilde S; Appelbaum S; Keller T; Ojeda-Echevarria F; Zeller T; Zwiener I; Sinning CR; Jagodzinski A; Schnabel RB; Lackner KJ; Münzel T; Blankenberg S; Wild PS; Sydow K
    Atherosclerosis; 2013 Jun; 228(2):451-9. PubMed ID: 23562132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homogeneous time-resolved fluoroimmunoassay for the measurement of midregional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR.
    Caruhel P; Mazier C; Kunde J; Morgenthaler NG; Darbouret B
    Clin Biochem; 2009 May; 42(7-8):725-8. PubMed ID: 19318039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Hartmann O; Morgenthaler NG; Anker SD
    J Am Coll Cardiol; 2011 Aug; 58(10):1057-67. PubMed ID: 21867843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR-Proadrenomedullin as biomarker of renal damage in urinary tract infection in children.
    Peñalver Penedo R; Rupérez Lucas M; Álvarez-Sala Walther LA; Torregrosa Benavent A; Casas Losada ML; Bañuelos Andrio L; Rebolledo Poves AB; Bueno Campaña M
    BMC Pediatr; 2021 Jun; 21(1):292. PubMed ID: 34187408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma midregional proadrenomedullin (MR-proADM) concentrations and their biological determinants in a reference population.
    Krintus M; Kozinski M; Braga F; Kubica J; Sypniewska G; Panteghini M
    Clin Chem Lab Med; 2018 Jun; 56(7):1161-1168. PubMed ID: 29432202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Adrenomedullin and Allelic Variation in the ADM Gene and Kidney Disease in People With Type 2 Diabetes.
    Velho G; Ragot S; Mohammedi K; Gand E; Fraty M; Fumeron F; Saulnier PJ; Bellili-Munoz N; Bouby N; Potier L; Alhenc-Gelas F; Marre M; Hadjadj S; Roussel R
    Diabetes; 2015 Sep; 64(9):3262-72. PubMed ID: 25948679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precursor proadrenomedullin influences cardiomyocyte survival and local inflammation related to myocardial infarction.
    Hinrichs S; Scherschel K; Krüger S; Neumann JT; Schwarzl M; Yan I; Warnke S; Ojeda FM; Zeller T; Karakas M; Keller T; Meyer C; Blankenberg S; Westermann D; Lindner D
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8727-E8736. PubMed ID: 30166452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.